Pdl Biopharma Inc

+

Pdl Biopharma Inc continues negative divergence & potential shift in direction

[BEARISH]: Pdl Biopharma Inc current price has highlighted recent selling pressure and the continuation of a bearish trading conditions. Currently, the CMF is -0.07. Pdl Biopharma Inc (NASDAQ:PDLI) received a confirmed CMF crossover days on the Aug 14 2019. The bearish signal has been active for 0 day. During the quarter, the lowest CMF value was -0.2 occurring on the Aug 14 2019.

This is the first day of buyer commitment for Pdl Biopharma Inc adding strength to an uptrend in the first timeframe

[BULLISH]: Pdl Biopharma Inc buyers are in control at the market close. This is the first day of buyer commitment for Pdl Biopharma Inc adding strength to an uptrend in the first timeframe & highlights the commitment of buyers to carry positions overnight. Over the last 12 months there has been 2 trading days with the closing price in the upper part of the range giving a confirmation ratio of 1.4%. Over the last month there has been 2 trading days with the closing price in the upper range giving a confirmation ratio of 16.7%. Currently this quarter, closing price has spent 2 days in the upper price range compared to 4 days in the lower range giving a ratio of 0.5x.

Continuation of the oversold CCI signal for Pdl Biopharma Inc

[BULLISH]: Pdl Biopharma Inc (NASDAQ:PDLI) current trading has maintained the Commodity Channel Index to oversold status and signalled the continuation of the bullish trading conditions. Currently, the CCI is -164. The bullish signal has been active for 6 days. During the quarter, the lowest CCI value was -195.

Load More
back to top